Brief: Hofseth Biocare Q2 EBIT at NOK 8.4 Million
Aug 25 (Reuters) - Hofseth Biocare Q2 revenue NOK 52.9 million. * Q2 EBIT NOK 8.4 million
Recent news on Hofseth Biocare ASA
See all newsBrief: HBC Publishes Clinical Trial, Calls It Paradigm-Changing
Brief: Hofseth Biocare Says Demand Outlook For 2026 Is Improving Rapidly
Norway's Hofseth Biocare Q4 revenue rises on Human Nutrition demand
Brief: Hofseth BioCare To Cancel Subsequent Offering
Brief: Hofseth Biocare Announces Results Of Subsequent Offering